A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma

Background: Interferons (IFNs) have been implemented as anti-tumor immunity agents in clinical trials of glioma, but only a subset of glioblastoma (GBM) patients profits from it. The predictive role of IFNs stimulated genes in GBM needs further exploration to investigate the clinical role of IFNs....

Full description

Bibliographic Details
Main Authors: Yong Xiao, Zhen Wang, Mengjie Zhao, Wei Ji, Chong Xiang, Taiping Li, Ran Wang, Kun Yang, Chunfa Qian, Xianglong Tang, Hong Xiao, Yuanjie Zou, Hongyi Liu
Format: Article
Language:English
Published: AIMS Press 2022-06-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2022441?viewType=HTML